Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1395 | Ribociclib | 3.16227766017 | 0.5009 | 0.02558 |
| MDA-MB-134-VI | AZD2014 | 3.16227766017 | -0.6759 | 0.16769 |
| MDA-MB-134-VI | AZD2014 | 3.16227766017 | -0.4420 | 0.20798 |
| MDA-MB-134-VI | AZD2014 | 3.16227766017 | -0.5928 | 0.17359 |
| MDA-MB-468 | AZD2014 | 3.16227766017 | 0.3222 | 0.18100 |
| MDA-MB-468 | AZD2014 | 3.16227766017 | 0.3046 | 0.04199 |
| CAL-51 | BMS-265246 | 3.16227766017 | 0.6711 | 0.02154 |
| CAL-85-1 | AZD6738 | 3.16227766017 | 0.7458 | 0.00374 |
| CAL-85-1 | AZD6738 | 3.16227766017 | 0.9360 | 0.01275 |
| CAL-85-1 | AZD6738 | 3.16227766017 | 0.7631 | 0.01519 |
| CAL-51 | BMS-265246 | 3.16227766017 | 0.5825 | 0.02945 |
| CAL-51 | BMS-265246 | 3.16227766017 | 0.5945 | 0.01964 |
| MDA-MB-134-VI | AZD5363 | 3.16227766017 | 0.8122 | -0.02419 |
| MDA-MB-134-VI | AZD5363 | 3.16227766017 | 0.4345 | -0.01604 |
| MDA-MB-134-VI | AZD5363 | 3.16227766017 | 0.8936 | -0.02402 |
| MDA-MB-453 | LY3023414 | 3.16227766017 | 0.0259 | 0.04946 |
| MDA-MB-361 | RO-3306 | 3.16227766017 | 0.4065 | -0.00123 |
| MDA-MB-361 | RO-3306 | 3.16227766017 | 0.8535 | -0.01617 |
| HCC1395 | LY3023414 | 3.16227766017 | 0.2691 | 0.07109 |
| HCC1395 | LY3023414 | 3.16227766017 | 0.3176 | 0.03979 |
| HCC1395 | LY3023414 | 3.16227766017 | 0.3578 | 0.04345 |
| MDA-MB-134-VI | AZD6738 | 3.16227766017 | 0.6647 | -0.00981 |
| MDA-MB-134-VI | AZD6738 | 3.16227766017 | 1.0975 | -0.03839 |
| MDA-MB-134-VI | AZD6738 | 3.16227766017 | 0.8019 | -0.03383 |
| HCC1500 | SHP099 | 3.16227766017 | 1.1575 | -0.17121 |